Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening.
Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Reliability and Factor Structure.
Platelets provide a bounty of potential targets for therapy in multiple sclerosis.
The effect of supported standing in adults with upper motor neurone disorders: a systematic review.
Cytochrome P450 3A4 is the major enzyme responsible for the metabolism of laquinimod, a novel immunomodulator.
Sativex(®) in multiple sclerosis spasticity: a cost-effectiveness model.
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.
Cognitive and Behavioral Outcomes in Individuals With a History of Acute Disseminated Encephalomyelitis (ADEM).
Multiple Sclerosis: Validation of MR Imaging for Quantification and Detection of Iron.
Mutations affecting segment number and polarity in Drosophila.
Clinically isolated syndromes and the relationship to multiple sclerosis.
Multiple sclerosis symptom recrudescence at the end of the natalizumab dosing cycle.
Deep 3D Convolutional Encoder Networks with Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation.
Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population.
Tocilizumab, MS, and NMOSD.
Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.
Discovery of Biologically Active Oncologic and Immunologic Small Molecule Therapies using Zebrafish: Overview and Example of Modulation of T Cell Activation.
Demyelinating Diseases: Myeloperoxidase as an Imaging Biomarker and Therapeutic Target.
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.
A touch of MS: Therapeutic mislabeling.
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
Interpretation and visualization of non-linear data fusion in kernel space: study on metabolomic characterization of progression of multiple sclerosis.
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination.

Pages